Capstone Investment Advisors’s Tevogen Inc. Common Stock TVGN Stock Holding History

Capstone Investment Advisors’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-500	Closed	-$258K	–	1713
2022 Q4	$258K	Hold	500	–	–	﹤0.01%	1249
2022 Q3	$254K	Hold	500	–	–	﹤0.01%	1417
2022 Q2	$250K	Hold	500	–	–	﹤0.01%	1370
2022 Q1	$250K	Buy	+500	New	+$249K	﹤0.01%	1620

Other funds holding TVGN

CCP

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capstone Investment Advisors's TVGN Position: Q1 2023 in Review

Capstone Investment Advisors sold out of Tevogen Inc. Common Stock (TVGN) in Q1 2023, closing a stake of 500 shares — an estimated $258K sold.

Capstone Investment Advisors first reported a position in TVGN in Q1 2022 and held it in 4 quarters. The position peaked at $258K in Q4 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

Capstone Investment Advisors reported no remaining Tevogen Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Capstone Investment Advisors sold 500 Tevogen Inc. Common Stock shares in Q1 2023, an estimated $258K.
Capstone Investment Advisors first reported a position in Tevogen Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Capstone Investment Advisors's Tevogen Inc. Common Stock position peaked at $258K in Q4 2022.
4 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q1 2023.

Based on Capstone Investment Advisors's 13F filing for Q1 2023, filed 9 May 2023.